P. Korkolopoulou

Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer

P. Korkolopoulou, L Kaklamanis, Francesco Pezzella et al. · British Journal of Cancer · 1996 · 187 citations · Full text

Life Sciences, Immunology, Oncology +16

Rates of infiltration by macrophages and dendritic cells and expression of interleukin‐18 and interleukin‐12 in the chronic inflammatory lesions of Sjögren's syndrome: Correlation with certain features of immune hyperactivity and factors associated with high risk of lymphoma development

Menelaos N. Manoussakis, S Boiu, P. Korkolopoulou et al. · Arthritis & Rheumatism · 2007 · 181 citations

Medicine, Immunology, Pathology +17

MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor

P. Korkolopoulou, P. Christodoulou, Konstantinos Kouzelis et al. · British Journal of Cancer · 1997 · 99 citations · Full text

Medicine, Oncology, Pathology +15

The expression of the B‐cell marker mb‐1 (CD79a) in Hodgkin's disease

P. Korkolopoulou, J L Cordell, Margaret T. Jones et al. · Histopathology · 1994 · 63 citations

Medicine, Hematology, Pathology +8

p53, c-myc p62 and proliferating cell nuclear antigen (PCNA) expression in non-Hodgkin's lymphomas.

P. Korkolopoulou, J Oates, Christos Kittas et al. · Journal of Clinical Pathology · 1994 · 36 citations · Full text

Medicine, Oncology, Pathology +17